Search Results for 'amyris'

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

From Project to Player: The Digest’s 2017 Multi-Slide Guide to Amyris

September 21, 2017 |

In California, Amyris reported Q2 2017 revenues of $25.7M million, more than double the sales from 2016. The increase was driven by a major increase in product sales, primarily in the company’s personal care segment, as well as by significantly higher collaboration revenues. For many people, the key question is — what is Amyris becoming, and […]

Read More

Amyris posts 168% increase in revenue for 2017 Q2 over 2016 Q2

Amyris posts 168% increase in revenue for 2017 Q2 over 2016 Q2

August 12, 2017 |

In California, Amyris announced its net income of $620,000 and total revenue of $25.7 million for the second quarter, which was good news for investors who saw a 168% increase over the same period last year. Product sales were up over 159% from last year’s Q2 as well, with Biossance sales delivering outstanding results and […]

Read More

Amyris closes second $25 million tranche of financing

Amyris closes second $25 million tranche of financing

August 10, 2017 |

In California, Amyris, Inc. announced the closing of the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25-million investment from Koninklijke DSM N.V. with the remaining $25 million contributed by Vivo Capital. “We are pleased to have the support of […]

Read More

Amyris enters first production development and production agreement with DSM

Amyris enters first production development and production agreement with DSM

July 17, 2017 |

In California, Amyris announce it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM), the global science-based company active in health, nutrition and materials, to develop a food and nutrition molecule for which DSM is a major market provider. As part of the previously announced equity investment DSM […]

Read More

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows, there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

Two Up: Amyris, Queensland gamble on farnesene for SE Asia

June 22, 2017 |

  The Digest discovered this hand-written lyric, we think written with a thumbnail dipped in biocrude, near Amyris headquarters in Emeryville, California. Somewhere north of Byron Bay where Cooktown orchids grow, and cane is ever-present and the Pioneer River flows there’ll be a group of smarties along the coastal towns hawking tonnes of bio farnesene for a zillion yuan a […]

Read More

Amyris and Queensland team on commercial-scale biorefineries

Amyris and Queensland team on commercial-scale biorefineries

June 20, 2017 |

In Australia, Amyris, Inc. and the Government of Queensland announced the next step in their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, […]

Read More

T Minus 90. Amyris’ next 90 days will say much, and may say all

T Minus 90. Amyris’ next 90 days will say much, and may say all

May 21, 2017 |

Moving fast, but will escape velocity be reached? Amyris reports 164% product revenue jump — yet questions linger. In California, Amyris reported Q1 revenues of $13.0M compared with $8.8M for Q1 2016, and touted the “significant increase in product sales, primarily in the personal care and health and nutrition markets, offset by a slight decline […]

Read More

First $47 million investment tranche led by Royal DSM into Amyris closed

First $47 million investment tranche led by Royal DSM into Amyris closed

May 15, 2017 |

In California, Amyris, Inc. announced the closing of the first tranche of up to $95 million in planned equity financing that the company previously announced on May 8, 2017. The first tranche was approximately $47 million and was led by Koninklijke DSM N.V. (Royal DSM) with participation by qualified institutional buyers and accredited investors, including […]

Read More

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

May 11, 2017 |

In California, Amyris said it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the current success of the program. During 2016, the company shipped approximately $9 million of farnesene to Nenter for conversion to Vitamin E and expects 2017 shipments to Nenter to be about $20 million. […]

Read More